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Background
Ever since 2008, when evidence of artemisinin resistant
malaria was highlighted in Western Cambodia [1], the
need for new drugs with an original structure and novel
mechanisms of action is even more pressing. The study of
traditional remedies such as Cinchona bark or Artemisia
aerial parts led to the discovery of the most potent antima-
larials, bearing out that nature is still an incredible source
of inspiration. Based on this approach, we are developing
new synthetic antimalarial agents with an original struc-
ture inspired by nature.
Material and methods
In vitro antiplasmodial activity is evaluated against two
strains of P. falciparum (multiresistant K1 and chloro-
quino-resistant 7G8) with two different methods: the inhi-
bition of 3[H]-hypoxanthine incorporation assay and the
Plasmodium-LDH immunoassay detection kit. Cytotoxicity
assays are performed on two murine cell types (L6 and
Hepa) in order to estimate the selectivity index, with two
different viability tests: the resazurine assay and an MTT-
based approach. In vivo activity is performed according to
Peters’ experiment [2] on P. berghei ANKA murine model
at a dosing regimen of 100 mg/kg intraperitoneally.
Results
The isolation of an in vitro active biflavonoid from
Campno-sperma panamense (Anacardiaceae, IC50 = 480
nM, P. falciparum K1), led us to the development of sim-
plified synthetic analogs (MR series) with improved phar-
macological and pharmacokinetic profiles. Notably one of
them (MR70) exhibits a partial in vivo antimalarial activity
with a reduction of parasitaemia by 45% on day 4.
Conclusion
We described here the first substituted flavone showing an
in vivo antimalarial activity in a murine model. This
scaffold should be promising in the fight against malaria.
To understand its mechanism of action, we are currently
running differential metabolomics analysis by solid NMR
(coll. Pr. J. I. Namer, Strasbourg, France) to highlight some
potential impact on Plasmodium metabolic pathways.
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